Scarica l'app Stockscreener
39.78
0.73%
0.29
Dopo l'orario di chiusura:
39.78
Qiagen Nv Borsa (QGEN) Ultime notizie
Aug Gainers: Can Qiagen NV ride the EV waveTrade Volume Report & Free Technical Pattern Based Buy Signals - baoquankhu1.vn
Why is Qiagen (QGEN) down 9.4% since last earnings report? - MSN
AI in Omics Studies Market is Going to Boom | Major Giants QIAGEN, Microsoft, NVIDIA - openPR.com
JPMorgan Chase & Co. Has $33.09 Million Stake in Qiagen N.V. $QGEN - MarketBeat
Qiagen N.V. stock faces pressure amid genomics slowdown as DACH investors eye biotech resilience - AD HOC NEWS
Breakout Zone: Is Qiagen NV part of any major index2026 Volume & Daily Growth Stock Investment Tips - baoquankhu1.vn
Tracer Biotechnologies and QIAGEN to advance blood-based MRD testing for solid tumors - MSN
Institution Moves: Is Qiagen NV stock a smart retirement pick2026 Investor Takeaways & Growth Focused Entry Point Reports - baoquankhu1.vn
QIAGEN reports supervisory board member’s restricted stock unit vesting and share settlement - TipRanks
Agilent, Danaher could be potential buyers of Qiagenanalyst - MSN
Fundamentals Check: Does Qiagen NV align with a passive investing strategy2026 Sector Moves & Weekly Chart Analysis and Guides - baoquankhu1.vn
Qiagen N.V. stock rises on strong Q4 earnings and genomics demand surge amid AI biotech push - AD HOC NEWS
Qiagen (NYSE:QGEN) Hits New 12-Month LowShould You Sell? - MarketBeat
Qiagen Announces Form 20-F Annual Report Filing for 2025 Results - BioSpace
PTA-CMS: QIAGEN N.V.: Third country release according to Article 50 Para. 1, No. 2 of the WpHG [the German Securities Trading Act] - TradingView
Third country release according to Article 50 Para. 1, No. 2 of the WpHG [the German Securities Trading Act] - TradingView
Qiagen N : Annual Report for Fiscal Year Ending December 31, 2025 (Form 20-F) - marketscreener.com
Qiagen N.V. stock gains spotlight with new QuantiFERON-TB data amid genomics challenges - AD HOC NEWS
QIAGEN Highlights Newly Published Data Supporting Efficacy of QuantiFERON for TB Prevention - BioSpace
Qiagen N.V. stock faces headwinds from genomics slowdown amid new TB test data - AD HOC NEWS
Deutsche Bank downgrades Qiagen NV (QGEN) - MSN
Qiagen NV at Leerink Global Healthcare Conference Transcript - GuruFocus
QGEN: New Data Highlights Efficacy of QuantiFERON-TB Gold Plus T - GuruFocus
Qiagen announces newly published data supporting efficacy of QuantiFERON - TipRanks
[IRANNOTICE] QIAGEN N.V. SEC Filing - Stock Titan
Qiagen N.V. Stock (ISIN: NL0012169213) Faces Headwinds Amid Genomics Slowdown and Strategic Shifts - AD HOC NEWS
Qiagen Teams With Gencurix to Expand Digital PCR Cancer Assays - MSN
PTA-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG - TradingView
Release according to Article 40, Section 1 of the WpHG - TradingView
Moors & Cabot Inc. Acquires 154,851 Shares of Qiagen N.V. $QGEN - MarketBeat
Qiagen N.V. Stock (ISIN: NL0012169213) Drops 16.85% in March Amid Diagnostics Sector Headwinds - AD HOC NEWS
BlackRock Reports 10.6% Capital and 11.8% Voting Stake in Qiagen - The Globe and Mail
Qiagen N.V. Stock (ISIN: NL0012169213) Faces Pressure Amid Life Sciences Slowdown - AD HOC NEWS
Wellington Management Group LLP Lowers Stake in Qiagen N.V. $QGEN - MarketBeat
Qiagen N.V. $QGEN Position Raised by Perbak Capital Partners LLP - MarketBeat
Dnca Finance Acquires 39,063 Shares of Qiagen N.V. $QGEN - MarketBeat
Deutsche Bank upgrades Qiagen NV (QGEN) - MSN
Qiagen (NYSE:QGEN) Stock Rating Upgraded by Deutsche Bank Aktiengesellschaft - MarketBeat
Today's Analyst Upgrade: Deutsche Bank Recommends Buy for QGEN | QGEN Stock News - GuruFocus
Deutsche Bank Upgrades Qiagen NV(QGEN.US) to Buy Rating - 富途牛牛
Korea Investment CORP Sells 93,167 Shares of Qiagen N.V. $QGEN - MarketBeat
Deutsche Bank upgrades Qiagen stock rating to buy on valuation By Investing.com - Investing.com India
Deutsche Bank upgrades Qiagen stock rating to buy on valuation - Investing.com
QIAGEN NV : Upgraded to Buy by Deutsche Bank - marketscreener.com
Deutsche Bank Upgrades Qiagen NV (QGEN) to Buy - StreetInsider
Qiagen Q2 2025 Earnings Preview - MSN
Capital International Investors Boosts Holdings in Qiagen N.V. $QGEN - MarketBeat
BlackRock Builds Significant Stake in Qiagen with Over 11% of Voting Rights - The Globe and Mail
Assessing Qiagen (QGEN) Valuation After Recent Share Price Weakness - Yahoo Finance
Qiagen discloses Bank of America’s 3.05% stake following AFM notification - TipRanks
Qiagen (NYSE:QGEN) Downgraded by Zacks Research to Strong Sell - MarketBeat
Jefferies Financial Group Inc. Makes New Investment in Qiagen N.V. $QGEN - MarketBeat
Capital Group Private Client Services Inc. Reduces Stock Position in Qiagen N.V. $QGEN - MarketBeat
Qiagen gains after guidance raise - MSN
QIAGEN Receives U.S. Clearance for Gastrointestinal Panels on Fully Automated QIAstat-Dx Rise Syndromic Testing System - BioSpace
QIAGEN Receives U.S. Clearance for Gastrointestinal Panels on Fully Automated QIAstat-Dx Rise Syndro - PharmiWeb.com
Transcript : Qiagen N.V. Presents at Barclays 28th Annual Global Healthcare Conference, Mar-10-2026 08 - marketscreener.com
Natixis Advisors LLC Increases Stock Position in Qiagen N.V. $QGEN - MarketBeat
Qiagen N.V. (NYSE:QGEN) Given Average Recommendation of "Hold" by Analysts - MarketBeat
Molecular Diagnostics Market Outlook: Set to Grow at 10%+ CAGR Through 2031 as Precision Medicine and Genetic Testing Advance, Says Mordor Intelligence - GlobeNewswire Inc.
Qiagen N.V. $QGEN Shares Acquired by Barclays PLC - MarketBeat
0.25%
2.78%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):